Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E1224 vs Benznidazole in Chronic Chagas Disease
NCT01489228Phase 2Unknown
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Jun 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosravuconazole in Chagas disease, sponsored by Drugs for Neglected Diseases initiative. Status: unknown.
02
Drugs
fosravuconazole
03
Conditions
Chagas disease
Beyond the preview
Go deeper on NCT01489228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489228.